Boston Scientific ICDs
This article was originally published in The Gray Sheet
Executive Summary
Firm resumes shipments of its Livian and Renewal cardiac resynchronization therapy defibrillators and Confient, Prizm and Vitality implantable cardioverter defibrillators after receiving FDA approval for previously unauthorized manufacturing process changes, Boston Scientific announces May 21. On March 15, the firm pulled all ICDs and CRT-Ds from U.S. shelves because manufacturing changes were made without prior FDA authorization. The firm resumed shipments of Teligen ICDs and Cognis CRT-Ds in April with FDA's go-ahead (1"The Gray Sheet" April 19, 2010)
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 9 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.